1 |
Curtis EB, Walsh TD. Prescribing practices of a palliative care service. J Pain Symptom Manage 1993;8:312-6.
DOI
ScienceOn
|
2 |
McPherson ML. Performing a medication regimen review in hospice and palliative care. Am J Hosp Palliat Care 2001;18:193-9.
DOI
ScienceOn
|
3 |
Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 2005;8:876-81.
DOI
ScienceOn
|
4 |
Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 2007;15:1407-12.
DOI
ScienceOn
|
5 |
Chen LK, Chou YC, Hsu PS, Tsai ST, Hwang SJ, Wu BY, et al. Antibiotic prescription for fever episodes in hospice patients. Support Care Cancer 2002;10:538-41.
DOI
ScienceOn
|
6 |
Reinbolt RE, Shenk AM, White PH, Navari RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175-82.
DOI
ScienceOn
|
7 |
Shin HR, Jung KW, Won YJ, Kong HJ, Yim SH, Sung J, et al. National cancer incidence for the year 2002 in Korea. Cancer Res Treat 2007;39:139-49.
DOI
ScienceOn
|
8 |
Koh SJ, Lee KS, Hong YS, Yoo YS, Park HJ. Clinical change of terminally ill cancer patients at the end-of-life time. Korean J Hosp Palliat Care 2008;11:99-105.
과학기술학회마을
|
9 |
Yennurajalingam S, Zhang T, Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer 2007;15:471-5.
DOI
ScienceOn
|
10 |
De Lima L. International Association for Hospice and Palliative Care list of essential medicines for palliative care. Ann Oncol 2007;18:395-9.
|
11 |
De Lima L, Doyle D. The International Association for Hospice and Palliative Care list of essential medicines for palliative care. J Pain Palliat Care Pharmacother 2007;21:29-36.
DOI
ScienceOn
|
12 |
Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer 2009;17:745-8.
DOI
ScienceOn
|
13 |
Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005;56:286-90.
DOI
ScienceOn
|
14 |
Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med 2004;18:100-7.
DOI
ScienceOn
|
15 |
Fahlman C, Lynn J, Finch M, Doberman D, Gabel J. Potentially inappropriate medication use by Medicaid+Choice beneficiaries in the last year of life. J Palliat Med 2007;10:686-95.
DOI
ScienceOn
|
16 |
Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care 2006;15:74-9.
DOI
ScienceOn
|